Literature DB >> 1608684

Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia.

I M Forgie1, H Campbell, N Lloyd-Evans, M Leinonen, K P O'Neill, P Saikku, H C Whittle, B M Greenwood.   

Abstract

Approximately 500 children younger than 5 years old resident in 7 villages in a rural area of The Gambia were monitored closely for 1 year for episodes of acute lower respiratory tract infection (ALRI). Each episode was investigated with antigen detection techniques and antibody assays as well as culture for bacteria and viruses. A pathogen was identified in 76 (34.2%) of 222 cases with clinical signs of ALRI and in 34 (42%) of the 81 cases who, in addition, had radiologic evidence of ALRI. Evidence of infection with a bacterial pathogen, most commonly Streptococcus pneumoniae or Haemophilus influenzae, was obtained in 32 (14.4%) cases with clinical signs of ALRI (23.5% of those with radiologically proved pneumonia). Viral agents were cultured from 42 (19%) of 221 cases but also from 14 (14.6%) of 96 controls some of whom had minor symptoms of upper respiratory tract infection. In the absence of an outbreak of respiratory syncytial virus the viral agents recovered most often were influenza A and adenoviruses.

Entities:  

Mesh:

Year:  1992        PMID: 1608684     DOI: 10.1097/00006454-199206000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

Review 1.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

Review 2.  The epidemiology of pneumococcal infection in children in the developing world.

Authors:  B Greenwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

3.  Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study.

Authors:  Emmanuel Addo-Yobo; Dang D Anh; Hesham F El-Sayed; LeAnne M Fox; Matthew P Fox; William MacLeod; Samir Saha; Tran A Tuan; Donald M Thea; Shamim Qazi
Journal:  Trop Med Int Health       Date:  2011-05-04       Impact factor: 2.622

4.  Economic evaluation of pneumococcal conjugate vaccination in The Gambia.

Authors:  Sun-Young Kim; Gene Lee; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2010-09-03       Impact factor: 3.090

5.  Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population.

Authors:  S B Omer; A Sutanto; H Sarwo; M Linehan; I G G Djelantik; D Mercer; V Moniaga; L H Moulton; A Widjaya; P Muljati; B D Gessner; M C Steinhoff
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

Review 6.  Pandemic influenza in Africa, lessons learned from 1968: a systematic review of the literature.

Authors:  Justin R Ortiz; Kathryn E Lafond; Tiffany A Wong; Timothy M Uyeki
Journal:  Influenza Other Respir Viruses       Date:  2011-05-03       Impact factor: 4.380

7.  Respiratory syncytial virus genotypes circulating in urban Ghana: February to November 2006.

Authors:  Evangeline Obodai; Richard Asmah; Isaac Boamah; Bamenla Goka; John Kofi Odoom; Theophilus Adiku
Journal:  Pan Afr Med J       Date:  2014-10-06

Review 8.  A Review of Pediatric Critical Care in Resource-Limited Settings: A Look at Past, Present, and Future Directions.

Authors:  Erin L Turner; Katie R Nielsen; Shelina M Jamal; Amelie von Saint André-von Arnim; Ndidiamaka L Musa
Journal:  Front Pediatr       Date:  2016-02-18       Impact factor: 3.418

9.  The viral aetiology of influenza-like illnesses in Kampala and Entebbe, Uganda, 2008.

Authors:  Stephen Balinandi; Barnabas Bakamutumaho; John T Kayiwa; Juliette Ongus; Joseph Oundo; Anna C Awor; Julius J Lutwama
Journal:  Afr J Lab Med       Date:  2013-06-24

Review 10.  The Impact of RSV-Associated Respiratory Disease on Children in Asia.

Authors:  Maduja Vyanga Manike Divarathne; Rukshan Rafeek Ahamed; Faseeha Noordeen
Journal:  J Pediatr Infect Dis       Date:  2018-04-11       Impact factor: 0.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.